Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Samuel B Burnett und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-2, Cerebellum, Disease Models, Animal, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of the Vice President for Research, University of South Carolina, University of South Carolina, NIDCR NIH HHS.
Abstract (Originalsprache)
Variants in the PRKRA gene, which encodes PACT, cause the early-onset primary dystonia DYT-PRKRA, a movement disorder associated with disruption of coordinated muscle movements. PACT and its murine homolog RAX activate protein kinase R (PKR; also known as EIF2AK2) by a direct interaction in response to cellular stressors to mediate phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α). Mice homozygous for a naturally arisen, recessively inherited frameshift mutation, Prkralear-5J, exhibit progressive dystonia. In the present study, we investigated the biochemical and developmental consequences of the Prkralear-5J mutation. Our results indicated that the truncated PACT/RAX protein retains its ability to interact with PKR but inhibits PKR activation. Mice homozygous for the mutation showed abnormalities in cerebellar development as well as a severe lack of dendritic arborization of Purkinje neurons. Additionally, reduced eIF2α phosphorylation was noted in the cerebellum and Purkinje neurons of the homozygous Prkralear-5J mice. These findings indicate that PACT/RAX-mediated regulation of PKR activity and eIF2α phosphorylation plays a role in cerebellar development and contributes to the dystonia phenotype resulting from the Prkralear-5J mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA.
- Genetic Resource Center, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
ORCID-Profile: Rekha C Patel
Förderung
- Office of the Vice President for Research, University of South Carolina
- University of South Carolina
- NIDCR NIH HHS
- NIH HHS
- U.S. Department of Defense
- National Institutes of Health
Zitieren
APA
Burnett, S. B., Culver, A. M., Simon, T. A., Rowson, T., Frederick, K., Palmer, K., Murray, S. A., Davis, S. W., & Patel, R. C. (2024). Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050929
Vancouver
Burnett SB, Culver AM, Simon TA, Rowson T, Frederick K, Palmer K, et al. Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050929
BibTeX
@article{Burnett2024,
author = {Burnett, Samuel B and Culver, Allison M and Simon, Tricia A and Rowson, Taylor and Frederick, Kenneth and Palmer, Kristina and Murray, Stephen A and Davis, Shannon W and Patel, Rekha C},
title = {Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050929}
}
EUVIMED